BONDI SANDS BROAD SPECTRUM SPF 60 SUNNY CREAM FACE- avobenzone, homosalate, octisalate, octocrylene lotion

Bondi Sands Broad Spectrum SPF 60 Sunny Cream Face by

Drug Labeling and Warnings

Bondi Sands Broad Spectrum SPF 60 Sunny Cream Face by is a Otc medication manufactured, distributed, or labeled by Baxter Laboratories Pty. Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Active Ingredients Purpose

Avobenzone 3%, Sunscreen

Homosalate15%

Octisalate 5%

Octocrylene 10%

PURPOSE

Uses

• Helps prevent sunburn
• If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE

Stop use and ask a doctor if rash or irritation occurs.

WARNINGS

Warnings

• For external use only.
• Do not use on damaged or broken skin
• When using this product keep out of eyes. If eye contact occurs, rinse thoroughly with clean running water.

DOSAGE & ADMINISTRATION

Directions

• Shake well before use
• Apply liberally 15 minutes before sun exposure.
• Use a water resistant sunscreen if swimming or sweating.
• Reapply :
• immediately after towel drying
• at least every 2 hours
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

Limit time in the sun, especially from 10 a.m.- 2 p.m.

• Wear long-sleeved shirts, pants, hats, and sunglasses.
• Children under 6 months: Ask a doctor.

OTHER SAFETY INFORMATION

Other information

• Protect the product in this container from excessive heat anddirect sun
• You may report a serious adverse reaction to 888-339-7642; Monday - Friday , 9 am - 5 pm

INACTIVE INGREDIENT

Inactive Ingredients

Water/Aqua/Eau, Beeswax, Aloe Barbadensis Leaf Juice, Cetearyl Alcohol, Cyclopentasiloxane, Isopropyl Palmitate, Ceteareth-20,

Hibiscus Sabdariffa Fruit Extract, Cyclohexasiloxane, Benzyl Alcohol, Hydroxyacetopenone, Phenoxyethanol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Sodium Stearoyl Glutamate, Aminomethyl Propanediol, Tocopheryl Acetate, Sodium Carrageenan, Sodium Chloride.

PRINCIPAL DISPLAY PANEL

bondi sands

SPF 60 Sunny Cream

Face Lotion

Sunscreen Broad Spectrum SPF 60

1.69 FL. OZ (50mL)

INGREDIENTS AND APPEARANCE

BONDI SANDS BROAD SPECTRUM SPF 60 SUNNY CREAM FACE 
avobenzone, homosalate, octisalate, octocrylene lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70157-022
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	3 g  in 100 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	10 g  in 100 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W)	OCTISALATE	5 g  in 100 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	15 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
AMINOMETHYL PROPANEDIOL (UNII: CZ7BU4QZJZ)
CYCLOPENTASILOXANE (UNII: 0THT5PCI0R)
CYCLOHEXASILOXANE (UNII: XHK3U310BA)
CETEARETH-20 (UNII: YRC528SWUY)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
BENZYL ALCOHOL (UNII: LKG8494WBH)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S) (UNII: 8Z5ZAL5H3V)
SODIUM STEAROYL GLUTAMATE (UNII: 65A9F4P024)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
SODIUM CARRAGEENAN (UNII: 7CY8BVL34N)
BEESWAX (UNII: 2ZA36H0S2V)
ALOE BARBADENSIS LEAF JUICE (UNII: ZY81Z83H0X)
WATER (UNII: 059QF0KO0R)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
HIBISCUS SABDARIFFA WHOLE (UNII: UH3Z91Y49Y)
PHENOXYETHANOL (UNII: HIE492ZZ3T)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70157-022-01	150 mL in 1 TUBE; Type 0: Not a Combination Product	12/04/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	12/04/2024

Labeler - Baxter Laboratories Pty. Ltd. (740537709)